A loss-of-function variant of PTPN22 is associated with reduced risk of systemic lupus erythematosusValeria Orrù, Nunzio Bottini, Si‐Yu Tsai et al.|Human Molecular Genetics|2008Cited by 124
First clinical symptom as a prognostic factor in systemic sclerosis: results of a retrospective nationwide cohort studyManuel Rubio‐Rivas, Xavier Corbella, Melany Pestaña-Fernández et al.|Clinical Rheumatology|2017Cited by 47
Identification of novel genetic markers associated with the clinical phenotypes of systemic sclerosis through a genome wide association strategyOlga Y. Gorlova, A T Lee, Roel A. Ophoff et al.|Journal of Translational Medicine|2010Cited by 32
Combined mepacrine–hydroxychloroquine treatment in patients with systemic lupus erythematosus and refractory cutaneous and articular activityA. Ugarte, Guillermo Ruiz‐Irastorza, Sabrina Porta et al.|Lupus|2018Cited by 30
A Candidate Gene Approach Identifies an IL33 Genetic Variant as a Novel Genetic Risk Factor for GCAAna Márquez, Javier Martı́n, Roser Solans et al.|PLoS ONE|2014Cited by 21